New Initiative ALS ONE Sets Four Year Goal to an ALS Therapy

A team of distinguished ALS experts in Massachusetts have joined forces in a new collaborative effort called ALS ONE. ALS ONE strives to accelerate progress towards a therapy for ALS by leveraging the expertise of four outstanding research and patient care organizations in Massachusetts and by promoting data sharing and coordination of efforts among them. Founded by entrepreneur and person living with ALS, Kevin Gosnell, ALS ONE has set the ambitious goal of developing an ALS therapy within four years. The leadership team consists of Steve Perrin from the ALS Therapy Development Institute (ALS TDI), Robert Brown from University of Massachusetts Medical School, Ron Hoffman from Compassionate Care ALS, and Merit Cudkowitz, Nazem Atassi and James Berry from Massachusetts General Hospital/Harvard Medical School. In addition, the ALS Association and ALS Finding a Cure Foundation are working with ALS ONE to synergize their initiatives.

Click here to read more.

disease-als topic-randd
Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail